DUBAI, United Arab Emirates, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Future Market Insights estimates that the Hyperphosphatemia Market will experience a rapid expansion between the years 2023 and 2033. By ...

HPT, HP, and HK in the 7MM and a moderate sales growth forecast highlight market opportunities. Significant unmet needs and emerging pipeline products present avenues for market expansion and ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription The kidneys, in addition to removing toxins, ...

Please provide your email address to receive an email when new articles are posted on . “So, what can we do beyond binders?” he asked during the presentation. One method is to increase the frequency ...

Nov. 4, 2002 — Lanthanum carbonate (Fosrenol) is safe and effective for the treatment of hemodialysis patients with hyperphosphatemia, according to two presentations on Nov. 2 at the American Society ...

Future Market Insights projects that between 2023 and 2033, the hyperphosphatemia market would grow rapidly. The global market for pharmaceuticals treating hyperphosphatemia is predicted to expand at ...

Diabetes, COPD Raise Post-Kidney Transplant Readmission Rates High phosphate levels are associated with 3.3-fold increased odds of 28-day in-hospital mortality. Hyperphosphatemia predicts an increased ...

Tenapanor, a novel agent that has been submitted to the US Food and Drug Administration (FDA) for approval for the treatment of hyperphosphatemia in patients undergoing dialysis, moved a step closer ...

Early PSA Response to Abiraterone Predicts Better Outcomes In a 2-phased trial, hyperphosphatemia and is sequelae developed in a smaller proportion of patients taking activated charcoal compared with ...

Credit: Ardelyx. Xphozah is a first-in-class oral medication designed to block sodium/hydrogen exchange 3 in the GI tract. Xphozah ® (tenapanor) is now available to reduce serum phosphorus in adults ...

Report Ocean has released a new report on the Hyperphosphatemia Therapeutics market, offering a comprehensive analysis of various factors, including market restraints, drivers, and opportunities. The ...